Expression profiling comparisons of human PBMC treated with class I/IIb or class IIa HDAC inhibitors

The aim of this study was to identify differential gene expression resulting from the inhibition of class IIa HDACs in human PBMC.

20

Lobera M, Madauss KP, Pohlhaus DT, Wright QG, Trocha M, Schmidt DR, Baloglu E, Trump RP, Head MS, Hofmann GA, Murray-Thompson M, Schwartz B, Chakravorty S, Wu Z, Mander PK, Kruidenier L, Reid RA, Burkhart W, Turunen BJ, Rong JX, Wagner C, Moyer MB, Wells C, Hong X, Moore JT, Williams JD, Soler D, Ghosh S, Nolan MA